0.25 0.01 (4.17%)

New 52W Low in past week

1.2M XNAS Volume

High volume today

XNAS 19 Mar, 2025 3:04 PM (EDT)



Insider Trading disclosures for Jaguar Health Inc

The latest disclosure was made by John J. Micek in Jaguar Health Inc where a trade of 26,500 Stock option (right to buy) done was reported to US exchanges on Oct. 8, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
John J. Micek Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 26,500 26,500 - - Stock option (right to buy)
James J. Bochnowski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 23,200 23,200 - - Stock option (right to buy)
Lisa A. Conte Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 16,503 16,624 (0%) 0% 0 Common Stock
Lisa A. Conte Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 132,020 132,020 - - Stock option (right to buy)
Pravin R. Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 39,376 39,376 - - Stock option (right to buy)
Pravin R. Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 4,922 4,957 (0%) 0% 0 Common Stock
Steven R. King See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 39,376 39,376 - - Stock option (right to buy)
Steven R. King See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 4,922 4,951 (0%) 0% 0 Common Stock
Jonathan B. Siegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 26,500 26,500 - - Stock option (right to buy)
Carol R. Lizak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 4,280 4,297 (0%) 0% 0 Common Stock
Carol R. Lizak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 34,240 34,240 - - Stock option (right to buy)
Jonathan S. Wolin See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 4,922 4,955 (0%) 0% 0 Common Stock
Jonathan S. Wolin See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 39,376 39,376 - - Stock option (right to buy)
Anula Jayasuriya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Oct 2024 21,000 21,000 - - Stock option (right to buy)
Pravin R. Chaturvedi Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2024 871 871 - - Restricted stock units
Pravin R. Chaturvedi Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2024 871 2,141 (0%) 0% - Common Stock
Steven R. King See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2024 612 1,756 (0%) 0% - Common Stock
Steven R. King See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2024 612 612 - - Restricted stock units
Carol R. Lizak Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2024 431 1,042 (0%) 0% - Common Stock
Carol R. Lizak Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2024 431 431 - - Restricted stock units
Jonathan S. Wolin Chief of Staff, CCO & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2024 871 871 - - Restricted stock units
Jonathan S. Wolin Chief of Staff, CCO & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2024 871 2,012 (0%) 0% - Common Stock
Lisa A. Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2024 600 0 - - Restricted stock units
Lisa A. Conte Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2024 600 4,600 (0%) 0% - Common Stock
Pravin R. Chaturvedi Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2024 134 1,270 (0%) 0% - Common Stock
Pravin R. Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2024 134 0 - - Restricted stock units
Steven R. King See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2024 178 0 - - Restricted stock units
Steven R. King See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2024 178 1,144 (0%) 0% - Common Stock
Carol R. Lizak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2024 60 0 - - Restricted stock units
Carol R. Lizak Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2024 60 611 (0%) 0% - Common Stock
Jonathan S. Wolin Chief of Staff, CCO & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2024 89 1,141 (0%) 0% - Common Stock
Jonathan S. Wolin Chief of Staff, CCO & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2024 89 0 - - Restricted stock units
John J. Micek Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2023 68,568 80,701 (0%) 0% 0 Common Stock
James J. Bochnowski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2023 76,613 78,876 (0%) 0% 0 Common Stock
Lisa A. Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2023 383,605 387,605 (2%) 2% 0 Common Stock
Pravin R. Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2023 204,192 205,328 (1%) 1% 0 Common Stock
Steven R. King see remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2023 159,168 160,133 (1%) 1% 0 Common Stock
Jonathan B. Siegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2023 68,568 69,874 (0%) 0% 0 Common Stock
Carol R. Lizak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2023 142,088 142,745 (0%) 0% 0 Common Stock
Jonathan S. Wolin Chief of Staff, CCO & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2023 196,628 197,680 (1%) 1% 0 Common Stock
Anula Jayasuriya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2023 1,718 0 - - Restricted stock units
Anula Jayasuriya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2023 68,568 70,286 (0%) 0% 0 Common Stock
Anula Jayasuriya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2023 1,718 1,718 (0%) 0% 0 Common Stock
John J. Micek Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 1,145 1,306 (0%) 0% - Common Stock
John J. Micek Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 1,145 0 - - Restricted stock units
James J. Bochnowski Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 1,280 2,263 (0%) 0% - Common Stock
James J. Bochnowski Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 1,280 0 - - Restricted stock units
Lisa A. Conte Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 2,694 4,000 (0%) 0% - Common Stock
Lisa A. Conte Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 2,694 5,389 - - Restricted stock units
Steven R. King Chief of Sustainable Supply Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 611 1,224 - - Restricted stock units
Steven R. King Chief of Sustainable Supply Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 611 965 (0%) 0% - Common Stock
Jonathan B. Siegel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 1,145 0 - - Restricted stock units
Jonathan B. Siegel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 1,145 1,306 (0%) 0% - Common Stock
Carol R. Lizak Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 431 862 - - Restricted stock units
Carol R. Lizak Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 431 657 (0%) 0% - Common Stock
Jonathan S. Wolin Chief of Staff, CCO & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 871 1,742 - - Restricted stock units
Jonathan S. Wolin Chief of Staff, CCO & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2023 871 1,052 (0%) 0% - Common Stock
Anula Jayasuriya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2023 1,718 1,718 - - Restricted stock units
Lisa A. Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2023 600 600 - - Restricted stock units
Lisa A. Conte Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2023 600 1,306 (0%) 0% - Common Stock
Pravin R. Chaturvedi Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2023 44 88 (0%) 0% - Common Stock
Pravin R. Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2023 44 44 - - Restricted stock units
Steven R. King Chief of Sustainable Supply Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2023 177 177 - - Restricted stock units
Steven R. King Chief of Sustainable Supply Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2023 177 354 (0%) 0% - Common Stock
Carol R. Lizak Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2023 60 226 (0%) 0% - Common Stock
Carol R. Lizak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2023 60 60 - - Restricted stock units
Jonathan S. Wolin Chief of Staff, CCO & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2023 88 88 - - Restricted stock units
Jonathan S. Wolin Chief of Staff, CCO & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2023 88 181 (0%) 0% - Common Stock
Jonathan S. Wolin Chief of Staff, CCO & GC Purchase of securities on an exchange or from another person at price $ 0.03 per share. 31 Dec 2022 317 6,983 (0%) 0% 0.0 10 Common Stock
Lisa A. Conte Director, CEO and President Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2022 142,500 0 - - Employee Stock Option (right to buy)
Pravin R. Chaturvedi Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2022 31,667 0 - - Employee Stock Option (right to buy)
Steven R. King Chief of Sustainable Supply Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2022 42,223 0 - - Employee Stock Option (right to buy)
Carol R. Lizak Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2022 14,294 0 - - Employee Stock Option (right to buy)
Jonathan S. Wolin Chief of Staff, CCO & GC Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2022 21,112 0 - - Employee Stock Option (right to buy)
Gregory J. Divis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2022 12,133 0 - - Restricted stock units
Gregory J. Divis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2022 12,133 12,133 (0%) 0% - Common Stock
John J. Micek Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2022 12,133 0 - - Restricted stock units
John J. Micek Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2022 12,133 12,133 (0%) 0% - Common Stock
James J. Bochnowski Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2022 13,133 73,765 (0%) 0% - Common Stock
James J. Bochnowski Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2022 13,133 0 - - Restricted stock units
Jonathan B. Siegel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2022 12,133 12,133 (0%) 0% - Common Stock
Jonathan B. Siegel Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2022 12,133 0 - - Restricted stock units
Lisa A. Conte Director, CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2022 45,000 53,003 (0%) 0% - Common Stock
Lisa A. Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 45,000 90,000 - - Restricted stock units
Pravin R. Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 3,333 6,666 - - Restricted stock units
Pravin R. Chaturvedi Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2022 3,333 3,333 (0%) 0% - Common Stock
Steven R. King Chief of Sustainable Supply Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 13,333 26,666 - - Restricted stock units
Steven R. King Chief of Sustainable Supply Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2022 13,333 13,333 (0%) 0% - Common Stock
Carol R. Lizak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 4,513 9,028 - - Restricted stock units
Carol R. Lizak Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2022 4,513 12,481 (0%) 0% - Common Stock
Jonathan S. Wolin Chief of Staff, CCO & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 6,666 13,333 - - Restricted stock units
Jonathan S. Wolin Chief of Staff, CCO & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2022 6,666 6,666 (0%) 0% - Common Stock
Gregory J. Divis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 85,900 85,900 - - Restricted stock units
John J. Micek Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 85,900 85,900 - - Restricted stock units
James J. Bochnowski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 96,015 96,015 - - Restricted stock units
Pravin R. Chaturvedi Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 195,934 195,934 - - Restricted stock units
Steven R. King Chief of Sustainable Supply Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 137,685 137,685 - - Restricted stock units
Jonathan B. Siegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 85,900 85,900 - - Restricted stock units
Jonathan S. Wolin Chief of Staff, CCO & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 196,018 196,018 - - Restricted stock units
James J. Bochnowski Director Sale of securities on an exchange or to another person at price $ 1.74 per share. 03 Jun 2021 152 954,390 (6%) 0% 1.7 264 Common Stock
James J. Bochnowski Director Sale of securities on an exchange or to another person at price $ 1.75 per share. 03 Jun 2021 292 954,542 (6%) 0% 1.8 511 Common Stock
Gregory J. Divis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 36,400 36,400 - - Restricted stock units
Gregory J. Divis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 72,750 72,750 - - Stock option (right to buy)
John J. Micek Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 72,750 72,750 - - Stock option (right to buy)
John J. Micek Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 36,400 36,400 - - Restricted stock units
James J. Bochnowski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 39,400 39,400 - - Restricted stock units
James J. Bochnowski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 78,750 78,750 - - Stock option (right to buy)
Jonathan B. Siegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 72,750 72,750 - - Stock option (right to buy)
Jonathan B. Siegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 36,400 36,400 - - Restricted stock units
Lisa A Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2021 405,000 405,000 - - Restricted stock units
Lisa A Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2021 810,000 810,000 - - Stock option (right to buy)
Steven R. King Chief of Sustainable Supply Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2021 120,000 120,000 - - Restricted stock units
Steven R. King Chief of Sustainable Supply Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2021 240,000 240,000 - - Stock option (right to buy)
Carol R. Lizak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2021 81,250 81,250 - - Stock option (right to buy)
Carol R. Lizak Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2021 40,625 40,625 - - Restricted stock units
Jonathan S. Wolin Chief of Staff, CCO & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2021 120,000 120,000 - - Stock option (right to buy)
Jonathan S. Wolin Chief of Staff, CCO & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2021 60,000 60,000 - - Restricted stock units
Gregory J. Divis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2020 26,533 26,533 - - Stock option (right to buy)
John J. Micek None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2020 26,533 26,533 - - Stock Option (right to buy)
James J. Bochnowski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2020 45,486 45,486 - - Stock Option (right to buy)
Lisa A Conte Director, Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2020 238,293 238,293 - - Stock Option (right to buy)
Steven R. King Executive VP and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2020 79,431 79,431 - - Stock Option (right to buy)
Jonathan B. Siegel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2020 45,486 45,486 - - Stock Option (right to buy)
Carol R. Lizak Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2020 50,000 50,000 - - Stock Option (right to buy)
Jonathan S. Wolin Chief of Staff, CCO & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2020 59,753 59,753 - - Stock Option (right to buy)
Gregory J. Divis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 121,573 121,573 - - Stock Option (right to buy)
John J. Micek None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 121,573 121,573 - - Stock Option (right to buy)
Steven R. King Executive VP and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 347,351 347,351 - - Stock Option (right to buy)
Karen Wright CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 303,932 303,932 - - Stock Option (right to buy)
Jeffrey C. Johnson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 121,573 121,573 - - Stock Option (right to buy)
Murray David MacNaughtan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 121,573 121,573 - - Stock Option (right to buy)
James J. Bochnowski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2019 208,410 208,410 - - Stock Option (right to buy)
James J. Bochnowski None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jul 2019 180,582 180,582 - - Series 2 Warrant to Purchase Common Stock
James J. Bochnowski None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jul 2019 180,582 180,582 - - Series 1 Warrant to Purchase Common Stock
James J. Bochnowski None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jul 2019 218,750 218,750 - - Bridge Warrant to Purchase Common Stock
James J. Bochnowski None Purchase of securities on an exchange or from another person at price $ 2.00 per share. 23 Jul 2019 180,582 181,618 (1%) 3% 2 361,164 Common Stock
Lisa A Conte Director, CEO and President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jul 2019 37,500 37,500 - - Bridge Warrant to Purchase Common Stock
Lisa A Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2019 1,042,052 1,042,052 - - Stock Option (right to buy)
Jonathan B. Siegel None Purchase of securities on an exchange or from another person at price $ 2.00 per share. 23 Jul 2019 12,705 13,276 (0%) 0% 2 25,410 Common Stock
Jonathan B. Siegel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2019 208,410 208,410 - - Stock Option (right to buy)
Jonathan B. Siegel None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jul 2019 12,705 12,705 - - Series 2 Warrant to Purchase Common Stock
Jonathan B. Siegel None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jul 2019 12,705 12,705 - - Series 1 Warrant to Purchase Common Stock
Jonathan B. Siegel None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jul 2019 34,375 34,375 - - Bridge Warrant to Purchase Common Stock
Jonathan B. Siegel None Purchase of securities on an exchange or from another person at price $ 0.60 per share. 04 Oct 2018 25,000 40,000 (0%) 0% 0.6 15,000 Common Stock
Jonathan M Glaser Other Gift of securities by or to the insider at price $ 0.00 per share. 25 Sep 2018 60,000 720,405 (7%) 0% 0 Common Stock
Lisa A Conte Director, CEO and President Purchase of securities on an exchange or from another person at price $ 1.11 per share. 18 Jul 2018 1,500 7,500 (0%) 0% 1.1 1,669 Common Stock
Jonathan B. Siegel None Purchase of securities on an exchange or from another person at price $ 1.10 per share. 18 Jul 2018 5,000 14,732 (0%) 0% 1.1 5,476 Common Stock
Jonathan B. Siegel None Purchase of securities on an exchange or from another person at price $ 1.19 per share. 17 Jul 2018 268 15,000 (0%) 0% 1.2 319 Common Stock
Gregory J. Divis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2018 104,860 104,860 - - Stock Option (right to buy)
Murray David MacNaughtan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2018 104,860 104,860 - - Stock Option (right to buy)
Lisa A Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 447,935 447,935 - - Stock Option (right to buy)
Steven R. King Executive VP and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 149,311 149,311 - - Stock Option (right to buy)
Karen Wright CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 85,854 85,854 - - Stock Option (right to buy)
Jeffrey C. Johnson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 104,860 104,860 - - Stock Option (right to buy)
Jonathan B. Siegel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2018 104,860 104,860 - - Stock Option (right to buy)
John J. Micek None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 38,643 38,643 - - Stock Option (right to buy)
John J. Micek None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 146,804 146,804 - - Stock Option (right to buy)
James J. Bochnowski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 251,665 251,665 - - Stock Option (right to buy)
James J. Bochnowski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 71,709 71,709 - - Stock Option (right to buy)
Lisa A Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 3,247,242 3,247,242 - - Stock Option (right to buy)
Steven R. King Executive VP and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 1,327,881 1,327,881 - - Stock Option (right to buy)
Jiahao Qiu None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 12,965 12,965 - - Stock Option (right to buy)
Zhi Yang None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 12,965 12,965 - - Stock Option (right to buy)
Folkert W. Kamphuis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 53,164 53,164 - - Stock Option (right to buy)
Karen Wright Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 998,857 998,857 - - Stock Option (right to buy)
Ari Azhir None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2018 39,286 39,286 - - Stock Option (right to buy)
Lisa A Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2017 285,807 285,807 - - Stock Option (right to buy)
Steven R. King Executive VP and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2017 95,269 95,269 - - Stock Option (right to buy)
Karen Wright CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2017 54,295 54,295 - - Stock Option (right to buy)
James J. Bochnowski None Purchase of securities on an exchange or from another person at price $ 0.50 per share. 28 Jun 2017 100,000 797,935 (5%) 0% 0.5 50,000 Common Stock
John J. Micek None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2016 10,884 10,884 - - Stock Option (right to buy)
James J. Bochnowski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2016 16,378 16,378 - - Stock Option (right to buy)
Lisa A Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2016 16,998 16,998 - - Stock Option (right to buy)
Steven R. King Executive VP and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2016 4,496 4,496 - - Stock Option (right to buy)
Folkert W. Kamphuis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2016 13,771 13,771 - - Stock Option (right to buy)
Karen Wright Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2016 2,866 2,866 - - Stock Option (right to buy)
Roger J. Waltzman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Dec 2016 2,866 2,866 - - Stock Option (right to buy)
James J. Bochnowski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2016 75,000 75,000 - - Stock Option (right to buy)
Lisa A Conte Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2016 318,000 318,000 - - Stock Option (right to buy)
Steven R. King Executive VP and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2016 23,042 23,042 - - Stock Option (right to buy)
Folkert W. Kamphuis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2016 13,000 13,000 - - Stock Option (right to buy)
Karen Wright Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2016 103,698 103,698 - - Stock Option (right to buy)
Folkert W. Kamphuis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2016 50,000 50,000 - - Stock Option (right to buy)
Roger J. Waltzman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2016 127,500 127,500 - - Stock Option (right to buy)
James J. Bochnowski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 11,293 11,293 - - Stock option (right to buy)
Lisa A Conte Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 85,616 85,616 - - Stock option (right to buy)
Lisa A Conte Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 69,970 69,970 - - Stock option (right to buy)
Lisa A Conte Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 113,212 113,212 - - Stock option (right to buy)
Steven R. King Executive VP and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 28,263 28,263 - - Stock option (right to buy)
Steven R. King Executive VP and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 49,942 49,942 - - Stock option (right to buy)
Jiahao Qiu None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 1,901 1,901 - - Stock option (right to buy)
Zhi Yang Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 1,901 1,901 - - Stock option (right to buy)
Folkert W. Kamphuis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 9,504 9,504 - - Stock option (right to buy)
Karen Wright Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2016 3,802 3,802 - - Stock option (right to buy)
Philippe Brianceau Chief Veterinary Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2016 20,000 20,000 - - Stock Option (right to buy)
James J. Bochnowski None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Feb 2016 160,000 487,576 - - Common Stock
James J. Bochnowski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2015 20,000 20,000 - - Stock option (right to buy)
Jiahao Qiu None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2015 10,000 10,000 - - Stock option (right to buy)
Zhi Yang Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2015 10,000 10,000 - - Stock option (right to buy)
Folkert W. Kamphuis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2015 50,000 50,000 - - Stock option (right to buy)
John A. Kallassy CFO, COO, Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2015 13,365 13,365 - - Stock Option (right to buy)
James J. Bochnowski None 18 May 2015 224,499 0 - - Series A Preferred Stock
James J. Bochnowski None 18 May 2015 148,332 247,220 - - Common Stock
James J. Bochnowski None 18 May 2015 35,714 282,934 - - Common Stock
James J. Bochnowski None 18 May 2015 44,642 327,576 - - Common Stock
Michael Hauser Chf Veterinarian, Clinical Ops Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2015 73,000 73,000 - - Stock Option (right to buy)
Zhi Yang Director, Ten Percent Owner 18 May 2015 2,224,991 0 - - Series A Preferred Stock
Zhi Yang Director, Ten Percent Owner 18 May 2015 1,483,326 1,522,881 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures